The junctional adhesion molecule-C promotes neutrophil transendothelial migration in vitro and in vivo |
| |
Authors: | Chavakis Triantafyllos Keiper Tanja Matz-Westphal Rachel Hersemeyer Karin Sachs Ulrich J Nawroth Peter P Preissner Klaus T Santoso Sentot |
| |
Institution: | Department of Internal Medicine I, University Heidelberg, Im Neuenheimer Feld 410, D-69120 Heidelberg, Germany. triantafyllos.chavakis@med.uni-heidelberg.de |
| |
Abstract: | The third member of the family of junctional adhesion molecules (JAMs), JAM-3, also called JAM-C, was recently shown to be a novel counter-receptor on platelets for the leukocyte beta(2)-integrin Mac-1 (alphaMbeta(2), CD11b/CD18). Here, new functional aspects of the role of endothelial cell JAM-C were investigated. Endothelial cells express JAM-C, which is predominantly localized within junctions at interendothelial contacts, since it codistributes with a tight junction component, zonula occludens-1. Whereas JAM-C does not participate in neutrophil adhesion to endothelial cells, it mediates neutrophil transmigration in a Mac-1-dependent manner. In particular, inhibition of JAM-C significantly reduced neutrophil transendothelial migration, and the combination of JAM-C and platelet/endothelial cell adhesion molecule-1 blockade almost completely abolished neutrophil transendothelial migration in vitro. In vivo, inhibition of JAM-C with soluble mouse JAM-C resulted in a 50% reduction of neutrophil emigration in the mouse model of acute thioglycollate-induced peritonitis. Thus, JAM-C participates in neutrophil transmigration and thereby provides a novel molecular target for antagonizing interactions between vascular cells that promote inflammatory vascular pathologies. |
| |
Keywords: | |
本文献已被 PubMed 等数据库收录! |
|